The success of Sildenafil initially fueled a surge for pharma, but recent shifts present a complicated picture for shareholders. Generic competitors are reducing revenue, and persistent litigation add more complexity https://shaniafwqb229290.bleepblogs.com/41480320/viagra-and-big-pharma-a-precarious-investment